Pulse Biosciences, Inc. (PLSE)
18.58
+0.48
(+2.65%)
USD |
NASDAQ |
Mar 05, 16:00
18.57
-0.01
(-0.05%)
After-Hours: 20:00
Pulse Biosciences Cash from Investing (Quarterly) : -0.105M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Artivion, Inc. | -30.51M |
| Edwards Lifesciences Corp. | -198.30M |
| Zimmer Biomet Holdings, Inc. | -322.00M |
| PetVivo Holdings, Inc. | 0.0051M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.76M |
| Cash from Financing (Quarterly) | 0.381M |
| Free Cash Flow | -54.46M |
| Free Cash Flow Per Share (Quarterly) | -0.2192 |
| Free Cash Flow to Equity (Quarterly) | -14.50M |
| Free Cash Flow to Firm (Quarterly) | -14.86M |
| Free Cash Flow Yield | -4.35% |